Connect with us

Hi, what are you looking for?

Health

Deterioration of Brain Cells in Parkinson’s Disease Is Slowed by Blocking the Bach1 Protein, Preclinical Study Shows

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, afflicting more than 10 million people worldwide and more than one million Americans. While there is no cure for PD, current therapies focus on treating motor symptoms and fail to reverse, or even address, the underlying neurological damage. In a new study, researchers at the Medical University of South Carolina (MUSC) have identified a novel role for the regulatory protein Bach1 in PD. Their results, published on Oct. 25 in the Proceedings of the National Academy of Sciences, showed that levels of Bach1 were increased in postmortem PD-affected brains, and that cells without Bach1 were protected from the damages that accumulate in PD. In collaboration with vTv Therapeutics, they identified a potent inhibitor of Bach1, called HPPE, that protected cells from inflammation and the buildup of toxic oxidative stress when administered either before or after the onset of disease symptoms.

Article: medicalxpress.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tech

Post Content Original Post: bleepingcomputer.com

Health

Tumbling COVID-19 case counts have some schools around the U.S. considering relaxing their mask rules, but deaths nationally have been ticking up over the...

Entertainment

The dazzling drone display celebrated not only the 25-year anniversary of EDC, but also the brand’s momentous return after a turbulent 2020. EDC Las...

Tech

This week, international law enforcement operations went on the offensive, making arrests in numerous countries for ransomware-related activities. […] Original Post: bleepingcomputer.com

BIVMedia.com